Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount ...

Eli Lilly’s GLP-1 pill helped some participants lose up to 15% body weight. But is it as effective as the injection? Here's ...

Eli Lilly's stock dipped after drug trial results, but strong Q2 2025 earnings and market position make it a strong buy. Read ...

Eli Lilly is seeing strong growth from its weight loss drugs. Investors are nervous about tariffs on drugs and weak data from ...

Eli Lilly says their obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for ...

Eli Lilly & Co has experienced a significant stock price decline of 18.64% over the past week, largely due to disappointing ...

Before receiving Emmy nominations for ‘Nobody Wants This,’ the actress received acclaim for her performance in ‘Veronica Mars ...

Jonathan Lilly, a 1997 Jim Thorpe graduate, was a standout baseball player for the Olympians. Lilly excelled as a three-year ...

No, Weapons is not based on a true story. The film's unsettling disappearances, witchcraft and other supernatural aspects ...

Biocon Biologics Ltd, the biosimilars unit of biopharmaceutical giant Biocon and its largest revenue driver, expects to ...

The past week saw market turbulence, with President Trump's new gold tariffs, Eli Lilly's dramatic stock drop, a weakening ...

Rather, it was the Danish pharmaceutical company's No. 1 rival. Appreciative investors bid up Novo Nordisk's stock in a ...